Author Correction: Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
Nat Commun
.
2022 Jul 7;13(1):3927.
doi: 10.1038/s41467-022-30946-9.
Authors
Sushil Kumar
1
,
Ajeya Nandi
1
,
Snahlata Singh
1
,
Rohan Regulapati
1
,
Ning Li
1
,
John W Tobias
2
,
Christian W Siebel
3
,
Mario Andres Blanco
1
,
Andres J Klein-Szanto
4
,
Christopher Lengner
1
,
Alana L Welm
5
,
Yibin Kang
6
,
Rumela Chakrabarti
7
Affiliations
1
Department of Biomedical Sciences, University of Pennsylvania, Philadelphia, PA, 19104, USA.
2
Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
3
Department of Discovery Oncology, Genentech Inc., South San Francisco, CA, 94080, USA.
4
Histopathology Facility, Fox Chase Cancer Center, Philadelphia, PA, USA.
5
Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, 84112, USA.
6
Department of Molecular Biology, Princeton University, Princeton, NJ, 08544, USA.
7
Department of Biomedical Sciences, University of Pennsylvania, Philadelphia, PA, 19104, USA.
[email protected]
.
PMID:
35798701
PMCID:
PMC9262875
DOI:
10.1038/s41467-022-30946-9
No abstract available
Publication types
Published Erratum